Anne Chew, PhD, is the Executive Deputy Director for the University of Pennsylvania (UPenn) Center for Cellular Immunotherapies (CCI) and one of the co-founders of Tmunity. She is responsible for overall strategic and operational leadership of all CCI-sponsored research programs and translational development initiatives in cell and gene therapy. Since 2006, she has served in senior regulatory, clinical operations, manufacturing operations and translational sciences roles at UPenn. Dr Chew has more than 15 years of translational research and development experience in both industry and academic settings. Together with Novartis, Dr Chew played a pivotal role in preparing the UPenn CTL019 submission to the FDA that was granted Breakthrough Designation, and served as Co-Chair on the UPenn-Novartis Global Program Team, which was responsible for CTL019 clinical development. Dr Chew received her undergraduate degree from Barnard College–Columbia University and her PhD in Genetics from Yale University School of Medicine